The balloon-expandable valve is already approved for use in India and Europe. New data presented at EuroPCR 2024 in Paris compared it to contemporary devices seen by many as the gold standard for TAVR care. 

In individuals who have not completed a DEXA scan, head CT conducted for other reasons can offer insight into patients’ frontal bone density, a potential marker of osteoporosis.

The new algorithm from Implicity evaluates implantable device data and monitors patients for changes that suggest they could experience severe heart failure symptoms in the near future. It was designed to alert clinicians up to weeks in advance.

Established guidelines recommend biopsying small tumors of the kidney ahead of any procedure to ablate them. A new study confirms the validity of pursuing another pathway.

Alcohol dependence and depression are known to affect the functional connectivity of the brain, but when the two co-occur, connectivity between certain regions is significantly worse, new MRI study shows.

Researchers tracked data from more than 600 patients, noting that heart teams may want to reconsider how they classify residual TR after treatment. 

HeartFlow's noninvasive Plaque Analysis technology, which uses AI to evaluate CCTA images, delivered assessments that mostly lined up with IVUS results. 

Atraverse Medical, a San Diego-based medical device company founded in 2022, designed the guidewire to give physicians as much freedom as possible while treating heart patients.